
The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Cancer Genomics Bioinformatician”
Reference: 2026-056-01
Application deadline: Until the position is filled
Number of vacancies: 1
The newly established Cancer Genome Dynamics Group led by Dr Carolin Sauer is seeking a highly motivated and skilled bioinformatician to join our growing research team. The successful candidate will play a critical role in implementing robust bioinformatic pipelines, analysing complex and large-scale genomic datasets with a particular focus on cell-free DNA, and in contributing to the advancements of our translational research programs with direct application to clinically relevant questions. This role is ideal for an individual with a strong bioinformatics background, hands-on experience with complex biological datasets, and a collaborative mindset with the motivation to work in an international and interdisciplinary research environment.
For more information or a recent and relevant list of publications, please visit https://vhio.net/pf/cancer-genome-dynamics-group/ and https://vhio.net/biosketch-carolin-sauer/
Main duties:
Multi-modal data analysis Analyse whole-genome sequencing (WGS) data (from both long- and short-read sequencing) of genomic tumour and cell-free DNA and contribute to the evaluation and development of novel computational methods.
Pipeline development and management Develop, optimise, implement and maintain scalable bioinformatic pipelines for processing and analysing complex genomic data.
Data integration and visualisation Integrate genomic data with other biological datasets and develop compelling visualisations to communicate complex findings.
Collaboration and communication Provide timely and expert bioinformatics support in a collaborative manner, present results at group meetings, and contribute to scientific publications.
Documentation and reproducibility Follow best practices for data and software management to ensure rigorous documentation, version control and reproducibility of all analyses, code and pipelines.
Requirements:
Mandatory:
Degree (preferably MSc or PhD) in Bioinformatics, Computational Biology, Computer Science, Biological Science or a closely related field.
Knowledge of processing and analysing cancer genomics and liquid biopsy datasets.
Proven experience in developing and running bioinformatics pipelines in high-performance computing (HPC) and Linux/Unix environments.
Demonstrated hands-on experience with bioinformatic software for cancer or human genomics.
Strong bash scripting and programming skills, preferably in Python and/or R.
Experience with environment and workflow management systems (e.g., Conda and Nextflow).
Proficiency with version control systems (e.g., Git).
Excellent written and verbal communication skills in English.
Ability to work collaboratively within an interdisciplinary team.
Desirable
Familiarity with long-read sequencing technologies (ONT or PacBio) and data analysis.
Experience and knowledge of statistical modelling or machine learning.
Additional information:
We offer:
📈The possibility of developing your professional career in a competitive environment.
🧠To be part of a center that is constantly developing, pursuing excellence in research and collaborating with leading teams.
🫱🏻🫲🏾We offer and promote a diverse and inclusive environment, and welcome all people equally, regardless of age, disability, gender, nationality, race, religion or sexual orientation.
🪴We care about our environment and understand the importance of sustainability. We have the GreenVhio program, which you can be a part of.
Conditions:
📝Permanent contract - Funding guaranteed for 2 years,plus possible extension.
🗓️Full-time position, 37.5 hours per week.
💶Salary according to qualifications and experience following VHIO pay scales.
💳Flexible remuneration program (includes restaurant vouchers/cards, transport, medical insurance, and “baby daycare” voucher).
⏰Flexible working hours and measures to balance work, family, and personal life, and promote gender equality, as established in the VHIO collective agreement.
🗺️24 days of holidays and 6 personal days.
🎓Fully subsidized Catalan, Spanish, or English courses.
🏃➡️Take advantage of doing sports at great prices with WellHub
🩺You’ll have access to weekly physiotherapy sessions at the office, offered at a reduced price for the team.
We encourage applications from candidates who meet most, even if not all, of the listed criteria.
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.

Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO) has established itself as a cancer research center of proven excellence internationally. It is thanks to Josep's directorship and VHIO's optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d´Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d´Hebron University Hospital physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO's pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread and more effectively treating even the most undruggable tumour types.
VHIO's translation toward precision oncology.